ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.
Ontology highlight
ABSTRACT: Estrogen signaling through estrogen receptor alpha (ER) plays a major role in endometrial cancer risk and progression, however, the molecular mechanisms underlying ER's regulatory role in endometrial cancer are poorly understood. In breast cancer cells, ER genomic binding is enabled by FOXA1 and GATA3, but the transcription factors that control ER genomic binding in endometrial cancer cells remain unknown. We previously identified ETV4 as a candidate factor controlling ER genomic binding in endometrial cancer cells, and here we explore the functional importance of ETV4. Homozygous deletion of ETV4, using CRISPR/Cas9, led to greatly reduced ER binding at the majority of loci normally bound by ER. Consistent with the dramatic loss of ER binding, the gene expression response to estradiol was
SUBMITTER: Rodriguez AC
PROVIDER: S-EPMC7073291 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA